Karyopharm Therapeutics (KPTI) Misses Q4 EPS by 5c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 0.55 +0.13 (30.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $19.41 | |||
| Open | $0.44 | 52 Week Low | $4.83 | |||
| Day High | $0.55 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $-2.74 | |||
| Volume | 7,474,496 | |||||
